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Cyclic dinucleotides (CDNs) play central roles in
bacterial pathogenesis and innate immunity. The
mammalian enzyme cGAS synthesizes a unique cy-
clic dinucleotide (cGAMP) containing a 2ʹ–5ʹ phos-
phodiester linkage essential for optimal immune
stimulation, but the molecular basis for linkage spec-
ificity is unknown. Here, we show that the Vibrio chol-
erae pathogenicity factor DncV is a prokaryotic
cGAS-like enzyme whose activity provides a mech-
anistic rationale for the unique ability of cGAS to
produce 2ʹ–5ʹ cGAMP. Three high-resolution crystal
structures show that DncV and human cGAS
generate CDNs in sequential reactions that proceed
in opposing directions. We explain 2ʹ and 3ʹ linkage
specificity and test this model by reprogramming
the human cGAS active site to produce 3ʹ–5ʹ cGAMP,
leading to selective stimulation of alternative STING
adaptor alleles in cells. These results demonstrate
mechanistic homology between bacterial signaling
and mammalian innate immunity and explain how
active site configuration controls linkage chemistry
for pathway-specific signaling.
INTRODUCTION
Cyclic dinucleotides (CDNs) are key regulators of both bacterial
physiology and mammalian innate immunity (Cai et al., 2014;
Danilchanka and Mekalanos, 2013). Cyclic di-guanosine
monophosphate (cdG) was originally discovered as a small-
molecule regulator of cellulose production in Acetobacter
(Ross et al., 1987), but it is now appreciated that cdG and cyclic
di-adenosine monophosphate (cdA) regulate diverse processes,
including biofilm formation, antibiotic signaling, and the bacterial
stress response (Danilchanka andMekalanos, 2013). In addition,cdG regulates developmental pathways in the eukaryote
Dictyostelium (Chen and Schaap, 2012). More recently, a mixed
base cyclic GMP-AMP molecule (cGAMP) was discovered in
Vibrio cholerae seventh pandemic strains, and the responsible
synthase, DncV, was identified as a virulence factor on
pandemic island-1 (Davies et al., 2012). Remarkably, cyclic
GMP-AMP was discovered shortly thereafter as the eukaryotic
signal responsible for triggering innate immune responses
downstream of cytosolic DNA recognition in mammalian cells
(Sun et al., 2013), and the human enzyme cyclic GMP-AMP
synthase (cGAS) is a major sensor for DNA-triggered innate
immunity (Li et al., 2013b; Schoggins et al., 2014). Despite the
prevalence of cyclic dinucleotide signaling in both prokaryotic
and eukaryotic kingdoms of life, it remains to be proven whether
a direct connection exists between the signaling machinery that
produces or responds to dinucleotides in either kingdom.
The bacterial cyclic dinucleotide synthases investigated to
date function as obligate oligomers in which each active site in
adjacent monomers generates one of the two phosphodiester
bonds necessary to produce the final symmetric cyclized prod-
uct (Chan et al., 2004; De et al., 2008; Witte et al., 2008). By
contrast, the mammalian cGAS enzyme functions with a single
active site, using a sequential series of reactions to produce a
mixed dinucleotide species G[2ʹ–5ʹ]pA[3ʹ–5ʹ]p (cGAMP) contain-
ing a 2ʹ–5ʹ phosphodiester bond (Ablasser et al., 2013; Diner
et al., 2013; Gao et al., 2013a; Zhang et al., 2013). The unique
2ʹ–5ʹ linkage in cGAMP has been shown to be responsible for
enhanced immunity through increased stimulation of the adaptor
STING (Diner et al., 2013; Gao et al., 2013b; Zhang et al., 2013),
but potential additional roles for the 2ʹ–5ʹ cGAMP linkage in sta-
bility or signal discrimination remain unknown.
The requirement for a mixed dinucleotide potentially drove
evolution of human cGAS to rely on a single active site and
sequential enzymatic reactions. However, the prokaryotic Vibrio
DncV enzyme also produces a mixed-base 3ʹ–5ʹ cGAMP mole-
cule (Ablasser et al., 2013; Davies et al., 2012; Diner et al.,
2013). Vibrio DncV has been hypothesized to function similarly
to cGAS (Diner et al., 2013; Gao et al., 2013a), but the lowCell 158, 1011–1021, August 28, 2014 ª2014 Elsevier Inc. 1011
Figure 1. Structure of Vibrio cholerae DncV
Reveals anAutoactivatedcGAS-like Enzyme
(A) Crystal structure of Vibrio cholerae DncV. a
helices are colored in green, b strands forming the
enzyme core are in blue, and a red circle marks the
active site.
(B) Superposition of the crystal structures of DncV
(green) and human cGAS (purple) (PDB 4KM5).
(C) Surface view representation of the DncV (green),
apo human cGAS (purple, ‘‘inactive’’), and dsDNA-
bound mouse cGAS (purple, ‘‘active’’) active site
substrate channels (mouse cGAS PDB 4K98).
Nucleotide substrate bindingpockets are colored in
blue, and the active site is marked by a red circle.
(D) Superposition of an electrostatic surface view
of DncV colored by charge (positive, blue and
negative, red) and cGAS-bound dsDNA (green).
The structures of DncV and dsDNA-bound mouse
cGAS were superposed without manual fitting of
the dsDNA ligand.
See also Figure S1.sequence homology (<10%) between DncV and mammalian
OAS/cGAS family enzymes precludes prediction about whether
DncV’s mechanism of action is functionally similar to cGAS or
to conventional oligomeric bacterial dinucleotide cyclases. We
reasoned that investigation of themolecular mechanism of Vibrio
DncV would reveal how enzymes that synthesize mixed cyclic
dinucleotides evolved in the prokaryotic kingdom. Such insights
could in turn provide a new framework to understand the distinct
ability of human cGAS to catalyze the 2ʹ–5ʹ linkage specificity
that is critical to innate immune signaling.
Here,wepresent a series of structures ofVibrio choleraeDncV,
capturing the enzyme in substrate bound and catalytically trap-
ped linear-intermediate states. In spite of the minimal sequence
identity, our results show that DncV is both a structural and func-
tional homolog of mammalian cGAS, demonstrating for the first
time a direct connection between the biosynthetic machinery
for generating dinucleotide signals in multiple kingdoms of life.
Although the active site shares a common architecture between
DncVandcGAS,weestablish that the sequential enzymatic reac-
tions proceed in opposite directions, with DncV using a 5ʹ pppA
[3ʹ–5ʹ]pG intermediate and cGAS a 5ʹ pppG[2ʹ–5ʹ]pA intermedi-
ate. By comparing the two enzymes, we derive a model that ex-
plains how single active site cyclases control phosphodiester
linkage specificity and how human cGAS rotates the substrate
nucleotides to produce the 2ʹ–5ʹ linkage unique to mammalian
innate immunity. This model allowed us to rationally redesign
the human cGAS active site for production of enzymatic variants
that nowsynthesize 3ʹ–5ʹ linked species. These results provide an
evolutionary connection between prokaryotic and eukaryotic
signaling systems andelucidate enzymatic plasticity that allowed
evolution of a unique metazoan innate immune molecule.
RESULTS AND DISCUSSION
Structure of Vibrio cholerae DncV Reveals an
Autoactivated cGAS-like Enzyme
We isolated a near-full-length construct of Vibrio cholerae DncV
(M4–L414) that retains full enzymatic activity and determined its1012 Cell 158, 1011–1021, August 28, 2014 ª2014 Elsevier Inc.3.0 A˚ resolution crystal structure. Selenomethionine derivatized
crystals were used for phase determination, and model
refinement was additionally improved by a higher-resolution
catalytically trapped intermediate structure (discussed below;
Table S1 available online). The core of DncV adopts a tem-
plate-independent nucleotidyl-transferase fold defined by b
strands b2–5, similar to the originally characterized CCA-adding
enzyme (Figure 1) (Xiong and Steitz, 2004). In spite of minimal
sequence identity (10%), the overall structure of DncV is
remarkably similar to that of human cGAS (Figures 1B and S1)
(Kato et al., 2013; Kranzusch et al., 2013; Li et al., 2013a; Zhang
et al., 2014). In addition, the catalytic core of DncV is nearly as
structurally conserved as the previously described relationship
between cGAS and the double-stranded RNA (dsRNA)-sensor
oligo-adenylate synthase (OAS) (root-mean-square deviation
[RMSD] 3.8 A˚ versus 3.0 A˚) (Civril et al., 2013; Donovan
et al., 2013; Kranzusch et al., 2013).
The structure of Vibrio DncV reveals an autoactivated state,
explaining why DncV is constitutively active, whereas cGAS
requires stimulation by dsDNA binding. Although the overall
fold of the core active site is shared, two unique features main-
tain constitutive activity of DncV. First, whereas dsDNA binding
is required to configure the cGAS active site for competent metal
ion coordination (Civril et al., 2013; Gao et al., 2013a), in DncV,
a-helical lobes brace either side of the active site and buttress
b strands b2–5 to automatically position D132, D134, and
D194 for divalent ion binding (Figure 1A). In agreement with
automatic positioning, the orientations of DncV D132, D134,
and D194 do not change between our apo and substrate bound
or catalytically trapped structures (discussed below). Second,
regulatory loops that restrict the substrate channel of cGAS
(Gao et al., 2013a) are missing in the DncV enzyme, resulting in
an open active site permanently competent for substrate binding
(Figures 1B, 1C, and S1). Recent structural studies have sug-
gested that complete activation of cGAS requires protein dimer-
ization (Li et al., 2013a; Zhang et al., 2014).We noted that purified
DncV behaves as a monomeric species, and there is no indica-
tion of functional dimerization within or between neighboring
asymmetric units of the crystals (Figure S2). In addition to remod-
eling that maintains an open and competent active site, these
results demonstrate that DncV lacks regulatory dimerization
contacts observed in eukaryotic cGAS and conventional bacte-
rial dinucleotide cyclases (De et al., 2008; Li et al., 2013a; Witte
et al., 2008; Zhang et al., 2014).
DncV does not require dsDNA binding to stimulate enzymatic
activity, and we therefore expected the basic DNA recognition
cleft found in cGAS to be absent. Strikingly, however, DncV
retains a long basic cleft with conserved residues along the
same face of the enzyme (Figures 1D and S1). Superposition of
the mouse cGAS-DNA-bound structure immediately positions
the dsDNA along this cleft without a need for manual docking
(Figure 1D). We therefore tested the impact of DNA and RNA
on DncV activity but saw no change in enzymatic behavior or
mobility of DncV in electrophoretic gel-shift assays (Figure S3).
The possible role of this cleft in DncV biology and Vibrio patho-
genicity remains an ongoing area of investigation.
DncV GTP Recognition Parallels cGAS Substrate
Discrimination
We next compared the nucleotide substrate preferences of
VibrioDncV and human cGAS enzymes. As expected, enhanced
product formation for each enzyme was observed in the pres-
ence of ATP andGTP (Figure 2A).We confirmed previous studies
(Davies et al., 2012; Diner et al., 2013) that, when provided only
ATP or only GTP, DncV synthesizes cdA and cdG (Figure 2A).
Promiscuity of the active site for nucleotide selection is shared
with human cGAS, which also inefficiently synthesizes both
cdA and cdG species when presented with ATP or GTP alone
(Figure 2A). Previous results with purified mouse cGAS were
unable to detect cdA formation (Gao et al., 2013a). Low levels
of human cGAS cdA formation may therefore indicate further
differences between the human andmouse homologs in addition
to variation in dependency of DNA-stimulated activation require-
ments (Kranzusch et al., 2013; Sun et al., 2013).
To ascertain the molecular basis of initial substrate selection,
we determined the crystal structure of DncV bound to a nonhy-
drolyzable nucleotide in which a methylene bridge replaces the
ɑ/b bridging oxygen (Apcpp or Gpcpp). The first step in cGAS
product formation involves coordination of the adenosine
triphosphate for 2ʹ hydroxyl attack by the guanosine ribose
(Gao et al., 2013a), but our initial crystallization attempts using
an ATP analog failed to reveal difference density compared to
the apo DncV structure. We therefore used the GTP analog
and, in this case, obtained crystals with strong difference density
for nucleotide, allowing us to determine the structure of DncV
bound to Gpcpp analog at 2.8 A˚ resolution (Figure 2B). The
boundGTP analog adopts an anti base configuration and follows
a similar path to the adenosine nucleotide residing in the phos-
phate-donor pocket observed in the catalytically inactive struc-
ture of the pig cGAS (E200Q/D202N) enzyme (Figure 2C) (Civril
et al., 2013). GTP is coordinated by base-specific hydrogen-
bonding interactions between amino acid D349 and the guanine
N1 and N2 positions along the Watson-Crick edge, whereas
bridging interactions between two bound divalent cations con-
nect the triphosphate moiety and the conserved DncV catalytic
triad D132, D134, and D194 (Figures 2D–2G). DncV crystalliza-tion conditions require high magnesium concentrations, and
the observed octahedral geometry of the bound metal ions (as
seen in our higher-resolution 1.8 A˚ catalytically trapped struc-
ture) is consistent with magnesium ion coordination (Figures
2E and 2F). In contrast to structures of cGAS, the base stacking
interaction between human cGAS Y436 and bound nucleotides
is notably absent in DncV. Instead, the tyrosine residue is re-
placed by I303 that retains active site pocket hydrophobicity
but prevents stabilization of particular base orientation (Figures
2D and 2G).
Prokaryotic and Metazoan Dinucleotide Cyclization
Reactions Proceed in Opposing Directions
We next crystallized DncV in the presence of combinations of
ATP/GTP and nonhydrolyzable Apcpp/Gpcpp analogs. Differ-
ence density was obtained for crystals of DncV with GTP and
Apcpp, and we determined the 1.8 A˚ resolution structure of
this complex (Figure 3A). Unexpectedly, the electron density
can clearly be traced for unambiguous assignment of a bound
linear dinucleotide intermediate pp(c)pA[3ʹ–5ʹ]pG, implying that
the first step in DncV nucleotide cyclization occurs through
adenosine 3ʹ hydroxyl attack of the guanosine a-phosphate
(Figure 3B). In this structure, the guanine and adenine bases
adopt anti and syn base configurations, respectively. This obser-
vation suggests that the DncV reaction proceeds through
a pppA(syn)[3ʹ–5ʹ]pG(anti) state similar to the mouse cGAS
pppG(syn)[2ʹ–5ʹ]pG(anti) structure, where the second nucleotide
to be hydrolyzed must pass through a syn conformation en route
to product cyclization (Gao et al., 2013a).
Hydrogen bonding interactions occur between Q113 and
the guanosine 2ʹ OH, and bridging water interactions between
T180 and I303/S302 backbone amines coordinate the guanosine
and adenosine riboses, respectively (Figure 3C). Interactions
with S115 and Y118, as well as the bridging metal B interactions,
stabilize the adenosine triphosphate, and in the linear intermedi-
ate state, bridging interactions with metal A further stabilize
the connecting A[3ʹ–5ʹ]pG phosphate (Figure 3C). The only inter-
actions with the nucleotide bases occur through the guanine
position where S260 and Y198 make contacts with the Wat-
son-Crick edge and Y198 and Q113 contact the Hoogsteen
edge (Figure 3C).
We next used combinations of a-radiolabeled substrates and
nonhydrolyzable nucleotides to test the order of DncV-catalyzed
reactions leading to cGAMP formation. Robust DncV linear dinu-
cleotide product formation occurred in reactions containing
[ɑ-32P]-GTP and nonhydrolyzable ATP, whereas no intermediate
product was observed in DncV reactions with [ɑ-32P]-ATP and
nonhydrolyzable GTP (Figure 3D). Conversely, linear dinucleo-
tide product formation was observed for human cGAS only in
the presence of [ɑ-32P]-ATP and nonhydrolyzable GTP (Fig-
ure 3D), confirming that the reaction with DncV proceeds primar-
ily through the linear dinucleotide intermediate pppA[3ʹ–5ʹ]pG,
whereas reaction with cGAS proceeds through pppG[2ʹ–5ʹ]pA
(Figures 3D and 3E). Together with crystallographic identification
of a linear pppA[3ʹ–5ʹ]pG intermediate, these results show that, in
spite of shared structural homology, the active sites of DncV and
cGAS produce cGAMP through sequential reactions that are




Figure 2. DncV GTP Recognition Parallels cGAS Substrate Discrimination
(A) Analysis of DncV and human cGAS cyclic dinucleotide product formation. Reactions were labeled with indicated ɑ-32P and unlabeled (‘‘cold’’) nucleotide
substrate, and all cGAS reactions included dsDNA. Reactions were treated with alkaline phosphatase and separated by thin layer chromatography. The lower
panel represents a longer exposure, and images are representative of multiple independent experiments.
(B) Crystal structure of DncV bound to Mg2+ ions (pink) and GTP analog (yellow/orange).
(C) Alignment of DncV (green) and cGAS (purple) substrate nucleotides derived from superposition of the DncV-GTP and pig cGAS-ATP/GTP (PDB 4KB6) crystal
structures.
(D) Zoomed view of GTP analog bound in the DncV active site.
(E and F) Cartoon schematic of DncV interactions with the catalytic Mg2+ ions (metal A and metal B). Octahedral coordination was initially determined by building
into the higher-resolution 1.8 A˚ maps of the catalytically trapped structure.
(G) Cartoon schematic of DncV interactions with the bound GTP analog as described in the Results.
See also Figure S3.Active Site Remodeling Controls Substrate Rotation and
Phosphodiester Linkage Specificity
To understand mechanistic control of phosphodiester linkage
specificity by cGAS-like enzymes, we compared the active site
positioning of our DncV trapped linear intermediate structure
(Figure 3) with that of the analogous mouse cGAS pppG[2ʹ–5ʹ]
pG structure (Gao et al., 2013a). Each dinucleotide is oriented
by similar base and phosphate backbone interactions (Figures
4A–4D), but superposition of the two bound ligands reveals sig-
nificant rotation of the dinucleotide base and ribose geometries
with respect to each other. In DncV, the bases are rocked up-1014 Cell 158, 1011–1021, August 28, 2014 ª2014 Elsevier Inc.ward 40 away from the catalytic triad, which is consistent
with repositioning of the 3ʹ or 2ʹ hydroxyl during the first phos-
phodiester bond formation (Figure 4E). Intriguingly, conserved
residues in either enzyme would be predicted to clash with the
alternative nucleotide orientations, indicating that each enzy-
matic pocket is specifically tailored to accept only one set of
base rotation conformations.
An extended side chain (Q113) at the bottom of the pocket
(site 1) and recessed side chain (I258) at the top of the pocket
(site 2) support the upward rotation of the bases in the DncV




Figure 3. Prokaryotic and Metazoan Dinucleotide Cyclization Reactions Proceed in Opposing Directions
(A) Crystal structure of DncV bound to Mg2+ ions (pink) and a linear pppA[3ʹ–5ʹ]pG intermediate (yellow/orange).
(B) Fo-Fc omit map of the pppA[3ʹ–5ʹ]pG ligand contoured to 4.5 s.
(C) Cartoon schematic of DncV interactions with the pppA[3ʹ–5ʹ]pG as described in the Results.
(D) Analysis of DncV and human cGAS cyclic dinucleotide product formation as in Figure 2A. Reactions include labeled/unlabeled NTPs and nonhydrolyzable,
methylene-substituted ATP and GTP nucleotides as indicated. A[3ʹ–5ʹ]pG (green) and G[2ʹ–5ʹ]pA (purple) labels denote migration of trapped linear products from
DncV and cGAS respectively, and the image is representative of multiple independent experiments.
(E) Reaction schematic of DncV and cGAS dinucleotide product formation.below and an extended R376 side chain at site 2 above the
bases induce the downward rotation of the bases in the cGAS
active site (Figures 4C, 4D, and 4E). The amino acids at sites 1
and 2 within the active site pocket share conserved combina-
tions of recessed or extended combinations of side chains,
such that, in general, prokaryotic DncV-like sequences encode
an extended amino acid in the site 1 position, whereas eukary-
otic cGAS-like sequences encode an extended amino acid in
site 2 (Figures 4F and 4G and Table S2). An additional discrimi-
nating characteristic is a conserved Y436 amino acid found in
all metazoan cGAS enzymes, where Y436 stacks with the bases
on the opposite side of the pocket (site 3); prokaryotic se-
quences favor nonpolar residues incapable of base-stacking
interactions in site 3 (Figures 4C–4G and Table S2). These differ-ences indicate that the location of extended amino acids in alter-
nate site 1 or site 2 positions, with a possible stabilizing role for
base-stacking interactions in site 3, direct rotation of the nucle-
otide bases to favor 3ʹ–5ʹ or 2ʹ–5ʹ linkage specificity.
Rational Reprogramming of Human cGAS Product
Formation
This proposedmodel of linkage specificity arising from our struc-
tures suggested that it may be possible to exchange recessed
and extended amino acid side chains at sites 1 through 3 to
re-engineer the catalytic activity of human cGAS. We therefore
replaced human cGAS site 1, 2, and 3 residues with the corre-
sponding prokaryotic DncV amino acids and purified seven
MBP-tagged mutant enzymes bearing single, double, or tripleCell 158, 1011–1021, August 28, 2014 ª2014 Elsevier Inc. 1015
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Figure 4. Active Site Remodeling Controls Substrate Rotation and Phosphodiester Linkage Specificity
(A and B) Zoomed view of the substrate binding pocket in the pppA[3ʹ–5ʹ]pG bound DncV structure (green) and pppG[2ʹ–5ʹ]pG bound mouse cGAS structure
(purple).
(C and D) Cartoon schematic illustrating site 1, 2, and 3 positions leading to altered substrate base rotation in DncV (green) and cGAS (purple).
(E) Superposition of bound linear intermediate substrates from DncV (green) and cGAS (purple) illustrating an 40 rotation in nucleotide base positioning.
(F) Schematic illustrating substrate rotation model where elongating amino acids in site 1 or site 2 reposition prokaryotic (green) and eukaryotic (purple) bases,
respectively.
(G) WebLogo illustration of site 1, 2, and 3 conservation in prokaryotic (green) and eukaryotic (purple) cGAS-like enzyme active sites. Text size correlates with
conservation across alignment of all available DncV and cGAS sequences (Crooks et al., 2004).
See also Figures S1 and S2 and Table S2.amino acid replacements to test for potentially altered catalytic
activity. We found that human cGAS R376I and T211Q/R376I
variant enzymes exhibit a significant change in dinucleotide
product migration as observed by thin layer chromatography,
implying altered product linkage specificity compared to the
wild-type (WT) G[2ʹ–5ʹ]pA[3ʹ–5ʹ]p enzyme product (Figure 5A).
Moreover, the mutant enzymes produce a dinucleotide species
that migrates similarly to the DncV 3ʹ–5ʹ cyclic dinucleotide spe-
cies. The human cGAS site 2 mutation R376I is most critical for
altered specificity, but the compensatory extended mutation of
T211Q in site 1 appears to increase enzymatic signaling potential
in a cellular context. Notably, alterations to this position are not
tolerated in the prokaryotic DncV enzyme (discussed below).
Conversely, the human cGAS site 3 Y436I mutation does not
impact product migration, and addition of the site 3 mutation
Y436I to create a triple mutant disrupts enzymatic activity, which
may result from too large of an increase of the active site pocket
or loss of base-stacking explicitly required for the altered activity
of the cGAS mutant enzymes (Figure 5A).
In addition to binding pocket restrictions impacting rotation of
the substrate nucleotides (Figure 4), the cGAS site 2 R376I mu-
tation may also relax guanine-specific base interactions to allow
altered product specificity. In each of our substrate-bound struc-
tures of DncV, nucleotide-specific interactions occur primarily
with the guanine base (Figures 2 and 3). Contacts are made pri-
marily through the guanine in the bound cGAS structures (Civril
et al., 2013; Gao et al., 2013a), indicating that, regardless of1016 Cell 158, 1011–1021, August 28, 2014 ª2014 Elsevier Inc.the opposing sequential order of reactions, DncV and cGAS
are naturally tuned to use guanine contacts for substrate posi-
tioning. Relaxing guanine-specific contacts while manipulating
residues at sites 1 through 3 may afford increased flexibility in
allowing altered rotation of substrate ligands.
To identify the altered products generated by human cGAS
R376I and T211Q/R376I enzymes, we first isolated and analyzed
the products with high-resolution mass spectrometry. Mass
spectrometry results confirm that the reprogrammed cGAS en-
zymes produce cyclic AMP-GMP, demonstrating that altered
product migration by thin layer chromatography is not due to
changes in base or chemical composition (Figure 5B). In agree-
ment with reprogramming mutations resulting in a relaxed
requirement for guanine-specific contacts, we also detect cdA
by high-resolution mass spectrometry (Figure 5B), and the
requirement for selecting the order of guanine incorporation is
now reduced (Figure S4). Importantly, the activity of reprog-
rammed cGAS enzymes retains the requirement for dsDNA stim-
ulation (Figure 5C), indicating that reprogrammingmutations that
alter the active site properties do not change the overall enzyme
function or ability to respond to DNA ligands.
Because mass spectrometry demonstrated that the engi-
neered cGAS variants produce cyclic AMP-GMP, we reasoned
that reduced product mobility is indeed caused by altered cyclic
dinucleotide chemical linkage and reprogramming of the enzy-
matic activity away from a metazoan-specific 2ʹ–5ʹ linkage. To
test this hypothesis, we conducted nuclease P1 digestions to
A C D
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Figure 5. Rational Reprogramming of Human cGAS Product Formation
(A) Analysis of DncV and human cGAS cyclic dinucleotide product formation as in Figure 2A. Reactions include DncV, WT cGAS, or the indicated cGAS mutant
enzymes, and migration of A[3ʹ–5ʹ]pG[3ʹ–5ʹ]p (DncV, green label) and WT G[2ʹ–5ʹ]pA[3ʹ–5ʹ]p (cGAS, purple label) products are indicated. MBP-tagged WT cGAS
produces more linear G[2ʹ–5ʹ]pA than untagged protein (see Figure 2A).
(B) High-resolution mass spectrometry analysis of cGAS R376I product formation confirms production of cyclic AMP-GMP, as well as cdA and linear
intermediates, as discussed in the Results.
(C) Dinucleotide analysis as in A, with WT cGAS or the indicated cGAS mutant enzymes in the presence of absence of dsDNA stimulation.
(D) Dinucleotide analysis as in A, with alkaline phosphate-treated products additionally digested with Nuclease P1 to hydrolyze all 3ʹ–5ʹ linkages (right lanes). WT
cGAS G[2ʹ–5ʹ]pA[3ʹ–5ʹ]p product is digested by Nuclease P1 to the indicated G[2ʹ–5ʹ]pA intermediate, whereas DncV and reprogrammed cGAS products are
digested to completion. Lower panels display increased exposures of the same experiments as in Figure 2, and images are representative of multiple
independent experiments.
See also Figures S3, S4, and S5.determine overall linkage specificity. Nuclease P1 hydrolyzes the
3ʹ–5ʹ phosphodiester bonds in cyclic dinucleotides but is unable
to digest the unique cGAS 2ʹ–5ʹ linkage (Ablasser et al., 2013;Diner et al., 2013). As expected, nuclease P1 treatment
completely degrades the DncV A[3ʹ–5ʹ]pG[3ʹ–5ʹ]p product,
whereas the WT cGAS product is digested to a G[2ʹ–5ʹ]pA linearCell 158, 1011–1021, August 28, 2014 ª2014 Elsevier Inc. 1017
A B Figure 6. Reprogrammed Human cGAS En-
zymes Signal Discrete Alleles of the Adaptor
STING
(A) In-cell reconstitution of cyclic dinucleotide
immune activation. Cells were cotransfected
with empty vector, human cGAS, or Vibrio DncV
plasmids in the presence of WT mouse STING
(mSTINGWT) or the R232H allele of human STING
incapable of responding to 3ʹ–5ʹ cGAMP (hSTING
R232H). Activating dsDNA was cotransfected in all
samples, and immune activation was monitored
with a firefly luciferase reporter under control of the
IFN-b promoter (pIFNb-FLuc).
(B) Cells were transfected as in A and included re-
programmed human cGAS enzymes as indicated.
Data are normalized to the empty vector control,
and error bars represent the SD from themean of at
least three independent experiments (the asterisk
denotesp<0.002, andn.s. denotesnot significant).
See also Figure S5.intermediate (Figure 5D). In contrast to the WT enzyme, cGAS
R376I and T211Q/R376I products gain sensitivity to nuclease
P1, confirming that they contain 3–5ʹ linkages (Figure 5D, right).
Selective signaling of reprogrammed cGAS enzymes through
only 30–50 permissive STING alleles in cells provides further
confirmation of 3ʹ–5ʹ cyclic dinucleotide production (see below).
Collectively, these data provide support for our structural model
of DncV and cGAS phosphodiester linkage control and demon-
strate successful reprogramming of the human cGAS enzyme to
produce 3ʹ–5ʹ linked dinucleotide products.
Active Site Plasticity Is Unique to Eukaryotic cGAS
Enzymes
Because alterations to amino acids at sites 1 and 2 reprogrammed
human cGAS to produce 3ʹ–5ʹ linked dinucleotide products, we
tested the corresponding eukaryotic amino acids in Vibrio DncV
to determine whether cGAS-like active site residues are sufficient
for conversion to 2ʹ–5ʹ product formation. We cloned seven Vibrio
DncV constructs with single, double, or triple human cGAS site 1,
2, and 3 substitutions and tested potential cyclic dinucleotide syn-
thesis activity in cells using a STING-dependent IFN-b luciferase
reporter assay. In contrast to human cGAS, DncV exhibited the
opposite pattern of substitution tolerance, whereby mutation of
site 1 to a recessed amino acid (Q113T) abolished all detectable
cyclic dinucleotide production, and mutation of site 2 to an
extended amino acid (I258R) did not impact enzymatic activity
(Figure S5). These results confirm a close relationship between
‘‘extended’’ and ‘‘recessed’’ amino acids at sites 1 and site 2 in
both prokaryotic and eukaryotic cGAS-like enzymes where, in
each case, the conserved extended amino acid plays a dominant
role. The observation that site 1 mutations in DncV abolish all
detectableactivitysuggests thatenzymeactivesiteplasticity lead-
ing to reprogramming is unique to eukaryotic cGAS enzymes
(Figure S5). These results demonstrate that modulation of a pro-
karyotic cGAS-like enzyme requires further alteration to the
enzyme active site in addition to a eukaryotic combination of re-
cessed/extended mutations at sites 1 and 2. Increased tolerance
in the human cGAS active site may be a prerequisite stage in the
evolution of the ability to catalyze two distinct phosphodiester1018 Cell 158, 1011–1021, August 28, 2014 ª2014 Elsevier Inc.bonds. It is possible that the uniqueability of human cGAS to allow
reprogramming to 3ʹ–5ʹ linkage specificity enables recreation of
a more ancestral state of the enzyme; further characterization
of ancestral cGAS-like homologs will be required to evaluate this
conclusion. The ability to reprogram human cGAS to synthesize
3ʹ–5ʹ specificproductswill allowscreening foradditionalmutations
that increase activity and further modulate active site chemistry.
Reprogrammed Human cGAS Enzymes Signal Discrete
Alleles of the Adaptor STING
We next tested the reprogrammed cGAS enzymes to determine
their ability to signal within cells and promote innate immune acti-
vation. Previous studies have demonstrated that distinct human
STING alleles exist and respond to different cyclic dinucleotide
repertoires (Ablasser et al., 2013; Diner et al., 2013; Jin et al.,
2011). Mouse STING responds to both 2ʹ–5ʹ cGAMP and canon-
ically linked 3ʹ–5ʹ cGAMP, cdA, and cdG. In contrast, the human
STING allele that encodes histidine at position 232 (R232H) re-
sponds only to 2ʹ–5ʹ cGAMP (Figure 6A) (Ablasser et al., 2013;
Diner et al., 2013). In agreement with our in vitro results, both
WT mSTING and hSTING R232H respond to the 2ʹ–5ʹ cGAMP
product of WT cGAS enzyme, but only the mSTING WT allele
responds to the product of reprogrammed cGAS enzymes,
now producing 3ʹ–5ʹ linked cyclic dinucleotides (Figure 6B).
Importantly, enzymatic reprogramming of the cGAS enzyme re-
sulted in a signaling pattern similar to WT DncV, further verifying
that the reprogrammed enzymes behave functionally as 3ʹ–5ʹ cy-
clic dinucleotide synthases, yet remain competent for cytosolic
DNA recognition and triggering of the antiviral cascade. Because
few mutations are required to alter cGAS product dinucleotide
linkage specificity, it will be of interest to determinewhether natu-
rally occurring cGAS enzymatic variants also synthesize 3ʹ–5ʹ
linked products. Endogenous signaling by 3ʹ–5ʹ linked cGAMP
could help account for the existence of STING alleles with
increased promiscuity in the human population (Jin et al., 2011).
Conclusions
The results presented here show that DncV is both a structural
and functional homolog of mammalian cGAS, demonstrating a
direct connection between the biosynthetic machinery for
generating dinucleotide signals in multiple kingdoms of life.
Our results provide evidence for an evolutionary relationship
between prokaryotic and eukaryotic signaling systems and sug-
gest an alternative to existing models hypothesizing that diver-
gence within the ancestral metazoan immune repertoire led to
creation of cGAS and OAS pathways separating cytosolic
dsDNA and dsRNA recognition (Cai et al., 2014; Civril et al.,
2013; Gao et al., 2013a; Kranzusch et al., 2013). It will be of
great interest to identify and compare further DncV and cGAS
homologs to determine whether genetic exchange played a
role in the development of cyclic dinucleotide signaling within
mammalian innate immunity. Crystal structures of DncV in sub-
strate bound and catalytically trapped linear-intermediate states
explain why human cGAS produces the 2ʹ–5ʹ linked cGAMP that
is unique to mammalian innate immunity. Rational redesign of
the human cGAS active site to create enzymatic variants that
synthesize 3ʹ–5ʹ linked species shows that relatively few muta-
tions allow for specific signaling through alternative STING
alleles. Our results reveal the potential existence of altered
cGAS-signaling and demonstrate the enzymatic plasticity




Vibrio cholerae DncV M4–L414 coding sequence (GenBank accession
CP003069) was amplified by PCR and cloned into a custom pET vector opti-
mized for E. coli expression of an N-terminal 6 3 His (KSSHHHHHHGSS)-
MBP-TEV fusion protein (Kranzusch and Whelan, 2011). Purification of DncV
was adapted from a previously developed protocol optimized for full-length
human cGAS, but for DncV, an ion-exchange step to remove bound nucleic
acid was not required. Briefly, BL21-RIL DE3 E. coli cells were cotransformed
with DncV expression vector and pRARE2 tRNA (Agilent) and grown in 23 YT
media at 37C to an OD600 of 0.5. Cells were cooled at 4C for 15 min,
induced with 0.5 mM IPTG, and incubated with shaking at 16C for 18 hr.
Cell pellets were washed with PBS, resuspended in lysis buffer (20 mM
HEPES-KOH [pH 7.5], 400 mM NaCl, 10% glycerol, 30 mM imidazole, and
1 mM TCEP) supplemented with EDTA-free Complete Protease Inhibitor
(Roche), and lysed by sonication. Clarified lysate was incubated with Ni-NTA
agarose (QIAGEN) for 1 hr at 4C, and recovered resin was washed with lysis
buffer supplemented to 1 M NaCl by gravity-flow chromatography at 4C.
Bound protein was eluted using lysis buffer supplemented to 300 mM imid-
azole, and MBP-tagged proteins were diluted to 50 mM imidazole and 5%
glycerol and concentrated to 40 mg ml1 prior to digestion with Tobacco
Etch Virus protease for15 hr at 4C. Digested protein was diluted in gel filtra-
tion buffer (20 mM HEPES-KOH [pH 7.5], 250 mM KCl, and 1 mM TCEP) and
passed over a 5 ml Ni-NTA column (QIAGEN) connected in line with a 5 ml
MBP-Trap column (GE Life Sciences) to remove protease and digested
MBP-tag. DncV protein was further purified by size-exclusion chromatography
on a Superdex 75 16/60 column in gel-filtration buffer, and eluted protein was
concentrated to 10–20 mg ml1. Purified protein was used immediately for
crystallography or supplemented with 10% glycerol and flash frozen in liquid
nitrogen and stored at 80C for biochemical experiments. For preparation
of selenomethionine-substituted DncV protein, cultures were grown in
M9 minimal media supplemented with 1 mM MgSO4, 100 mM CaCl2, 1 mg
ml1 thiamine, 0.4% glucose, and trace elements. After growth at 37C to
an OD600 of 0.4, cultures were supplemented with leucine, isoleucine, and
valine at 50 mg l1; phenylalanine, lysine, and threonine at 100 mg l1; and se-
lenomethionine (Acros Organics) at 75 mg l1. Cultures were grown at 37C for
an additional 30 min, cooled at 4C for 15 min, induced with 0.5 mM IPTG, and
incubated with shaking at 16C for 18 hr. Selenomethionine-substitutedprotein was purified using identical conditions as native protein except buffers
contained 2 mM TCEP.
Full-length human cGAS was expressed and purified as previously
described (Kranzusch et al., 2013). cGASmutants were generated by PfuUltra
polymerase (Stratagene) and QuikChange PCR and initially purified as MBP-
tagged proteins prior to dialysis overnight at 4C (20 mM HEPES-KOH 7.5,
150 mM KCl, 10% glycerol, and 1 mM TCEP). Dialyzed protein was concen-
trated and stored for biochemistry similar to purified DncV. cGAS R376I and
T211Q/R376I enzymes were subsequently purified with MBP-tag removal as
previously described (Kranzusch et al., 2013).
Crystallization and Structure Determination
Crystals of DncV were grown at 18Cby hanging-drop vapor diffusion. Purified
10 mg ml1 DncV protein was incubated on ice for 30 min with 5 mM NTP
combinations and 10.5 mM MgCl2. Following incubation, Easy-Xtal 15-well
trays (QIAGEN) were used to set 2 ml 1:1 or 0.8:1.2 (protein: reservoir) ratio
drops over 350 ml of reservoir solution. Additionally, for some NTP conditions,
crystallizationwas optimized by premixing protein-NTP and reservoir solutions
and incubating at room temperature for 10 min prior to brief centrifugation and
setting drops with mixture supernatant. Original crystallization conditions were
determined by sparse-matrix screen using 400 nl drops set over 70 ml reservoir
solutions in a 96-well format. Optimal crystallization conditions were 30 mM
HEPES-KOH [pH 7.5], 200–300 mM Mg(OAc)2 and 20–22% PEG-3350, but
slight refinements to these conditions were required for growth with different
substrates.
Crystals grew as clusters of rods and required incubation at 18C for
2–4 days for complete growth. Individual crystals were harvested by gently
tweezing the nucleation center with a nylon loop or a Kozak cat whisker to
release single rods. Crystals were transferred with a nylon loop to a new
drop containing reservoir solution supplemented with 15%–20% ethylene gly-
col or glycerol as a cryoprotectant and incubated for 15 s before flash freezing
in liquid nitrogen. Selenomethionine crystals were grown and harvested using
similar conditions and optimized by micro or streak-seeding crushed native
crystals with a Kozak cat whisker. Native and anomalous data were collected
under cryogenic conditions at the Lawrence Berkeley National Laboratory
Advanced Light Source (Beamline 8.3.1) and Stanford Synchotron Radiation
Lightsource (Beamlines 11.1 and 12.2).
X-ray diffraction data were processed with XDS and SCALA (Kabsch, 2010)
using the SSRL autoxds script (A. Gonzalez, SSRL). Indexed crystals belonged
to the orthorhombic space group P 21 with two copies of DncV in the asym-
metric unit. For phase determination, a series of independent data sets was
collected from a single large selenomethionine crystal using a microfocus
beam at the peak selenium absorbance energy. These data sets were then
merged to create a single high multiplicity data set, allowing selenium sites
to be identified with HySS within PHENIX (Adams et al., 2010). An initial map
was calculated using SOLVE/RESOLVE (Terwilliger, 1999), providing interpret-
able electron density for de novo building of a mixed poly-alanine and native
sequence model of one DncV monomer using Coot (Emsley and Cowtan,
2004). This partial structure was then used as a molecular replacement search
model to extend phases into a 1.8 A˚ native pppA[3ʹ–5ʹ]pG data set. Iterative
rounds of model building in Coot and refinement were conducted with PHENIX
until all interpretable electron density was modeled. Data for refinement of the
native pppA[3ʹ–5ʹ]pG structure were extended to 1.8 A˚, 0.2 A˚ beyond an I/s
resolution cutoff (1.98 A˚) as determined by CC* correlation and Rpim param-
eters (Karplus and Diederichs, 2012). The completed DncV model was then
used as a search model and reference restraint to build the remaining apo
and substrate-bound structures.
In Vitro Reconstitution of Cyclic Dinucleotide Synthesis and Nucleic
Acid Sensitivity
DncV and cGAS cyclic dinucleotide synthesis was performed and measured
as previously described (Kranzusch et al., 2013). Briefly, 1 mM of purified
enzyme or equivalent volume of gel-filtration buffer was incubated with
25 mM NTP substrates and 10 mCi radiolabeled [ɑ-32P]-ATP or [ɑ-32P]-
GTP (Perkin Elmer) as indicated. Reactions were performed in 10 ml of final re-
action buffer (50 mM KCl, 5 mM Mg(OAc)2, 50 mM Tris [pH 7.0], 1 mM TCEP,
0.1 mg ml1 BSA [NEB]) and incubated at 37C for 2 hr. All cGAS reactionsCell 158, 1011–1021, August 28, 2014 ª2014 Elsevier Inc. 1019
included 2 mM of a chemically synthesized 45 bp double-stranded immunos-
timulatory DNA (Integrated DNA Technologies) (Stetson andMedzhitov, 2006),
and DncV reactions include 2 mM of indicated nucleic acids as previously
described (Kranzusch et al., 2013). Following incubation, 5 ml of the reaction
volume were transferred to a new tube and treated with 5 units of alkaline
phosphatase (NEB) at 37C for 45 min to digest remaining unincorporated
labeled NTPs. Reactions were terminated by spotting 1 ml onto a PEI-cellulose
F thin-layer chromatography (TLC) plate (EMD Biosciences) and drying for
5 min at room temperature. TLC plates were developed with 1.5 M KH2PO4
(pH 3.8) and run until 2 cm from the top edge of an 20 cm plate. Plates
were dried at 80C for 30 min, and radiolabeled products were detected
with a phosphorscreen and Storm phosphorimager (GE Life Sciences). Where
indicated, reactions were additionally digested with 2 mU of Nuclease P1 from
Penicillium citrinum (Sigma) in 13 P1 buffer (30 mM NaOAc [pH 5.3], 0.4 mM
ZnSO4), following alkaline phosphatase treatment by incubating at 45
C for
30 min as previously described (Rahmeh et al., 2009). DncV electrophoretic
mobility shift assayswere preparedwith identical reaction conditions using nu-
cleic acid substrates labeled at the 5ʹ end with T4 PNK (NEB) and [ɣ-32P]-ATP
as previously described and separated on a 6% nondenaturing polyacryl-
amide gel with 0.5%TBE at 6W for 1.5 hr. Example images in figures are repre-
sentative of multiple independent experiments.
cGAS R376I Product Purification and Structural Characterization
The enzymatic reaction products from cGAS R376I were purified as previously
described using an Agilent HPLCwith mixed components from the 1200 series
and 1260 series (Diner et al., 2013). Briefly, purificationwas performed using an
Agilent Polaris C18-A column (4.6 3 250 mm, 5 mm). Purification conditions
included a 100% to 0% gradient of solvent A over 20 min at 50C and a flow
rate of 1 ml min1; solvent A was 100 mM ammonium acetate in water at
pH 7, and solvent Bwas acetonitrile. Purified elution fractionswere evaporated
multiple times in order to remove excess ammonia. Mass spectrometry
analysis was performed in the University of California, Berkeley, QB3 Mass
Spectrometry Facility.
HRMS (m/z): [M-H] calculated for C20H23N10O12P2, 657.0971; found,
657.0982.
HRMS (m/z): [M-H] calculated for C20H23N10O13P2, 673.0920; found,
673.0931.
Cell-Based IFN-b Luciferase Assay
Full-length cDNA sequences for Vibrio DncV, human cGAS, human mutant
STING (hSTING R232H), and WT mouse STING (mSTING WT) were cloned
into pcDNA vectors (Invitrogen) for mammalian cell expression. 293T cells
were seeded into opaque 96-well plates 20 hr prior to transfection at a density
optimized tobe75%–80%confluentat the timeof transfection.Cellswere trans-
fected as indicated along with a control Renilla luciferase reporter plasmid and
an IFN-b promoter Firefly luciferase reporter plasmid as previously described
(Inn et al., 2011; Kranzusch et al., 2013). At 24 hr posttransfection, Firefly and
Renilla luciferase values were measured using the Dual-Luciferase Reporter
Assay System (Promega) and a Veritas Microplate Luminometer (Turner Bio-
systems) according to the manufacturer’s protocols. IFN-b Firefly luciferase
expression was normalized to transfection efficiency by calculating the relative
expression of Firefly luciferase to Renilla luciferase activity. As indicated (Fig-
ure 6), data were combined frommultiple independent experiments, and statis-
tical significance was calculated with an unpaired, two-tailed t test in Prism.
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